Fig. 4: Peripheral blood NLR and survival outcomes in angiosarcoma. | npj Precision Oncology

Fig. 4: Peripheral blood NLR and survival outcomes in angiosarcoma.

From: Clinical implications of systemic and local immune responses in human angiosarcoma

Fig. 4: Peripheral blood NLR and survival outcomes in angiosarcoma.

a Patients with distant metastasis at diagnosis had higher NLR (p = 0.0129, Mann-Whitney U test) (Boxplot elements: center line, median; bounds of box, lower and upper quartiles; whiskers, minimum and maximum values.). b Progression of localized disease at diagnosis to metastatic relapse within the same patients was associated with an increase in NLR (p = 0.0007, Wilcoxon signed-rank test). c High NLR > 2.5 was independently associated with worse OS. d Patients were risk-stratified based on the “MAN” prognostic score into low (0–1), intermediate (2), and high (3) risk subgroups, which were associated with 1-year OS of 63.5%, 45.9%, and 17.4%, respectively.

Back to article page